1)Konishi T, Watanabe T, Nagawa H, et al:Preoperative chemoradiation and extended pelvic lymphadenectomy for rectal cancer:Two distinct principles. World J Gastrointest Surg 2:95-100, 2010
2)van Gijn W, Marijnen CAM, Nagtegaal ID, et al:Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer:12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol 12:575-582, 2011
3)大腸癌研究会(編):大腸癌治療ガイドライン医師用2010年.金原出版,2010
4)Kusters M, Beets GL, van de Velde CJ, et al:A comparison between the treatment of low rectal cancer in Japan and the Netherlands, focusing on the patterns of local recurrence. Ann Surg 249:229-235, 2009
5)Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med 336:980-987, 1997
6)Peeters KC, Marijnen CA, Nagtegaal ID, et al:The TME trial after a median follow-up of 6 years:increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 246:693-701, 2007
7)Bosset JF, Collette L, Calais G, et al;EORTC Radiotherapy Group Trial 22921:Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355:1114-1123, 2006
8)Sauer R, Becker H, Hohenberger W, et al;German Rectal Cancer Study Group:Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731-1740, 2004
9)An X, Lin X, Wang FH, et al:Short term results of neoadjuvant chemoradiotherapy with fluoropyrimidine alone or in combination with oxaliplatin in locally advanced rectal cancer:a meta analysis. Eur J Cancer 49:843-851, 2013
10)Tulchinsky H, Shmueli E, Figer A, et al:An interval>7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer. Ann Surg Oncol 15:2661-2667, 2008